Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.29 USD | +4.03% | +35.79% | +152.94% |
May. 06 | Oppenheimer Upgrades Chemomab Therapeutics to Outperform | MT |
Apr. 10 | Transcript : Chemomab Therapeutics Ltd. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+152.94% | 18.34M | |
+18.72% | 125B | |
+14.53% | 109B | |
-2.88% | 24.74B | |
+4.45% | 22.67B | |
-9.74% | 18.14B | |
-41.04% | 16.67B | |
-11.83% | 16.64B | |
+1.46% | 13.45B | |
+24.22% | 11.32B |
- Stock Market
- Equities
- CMMB Stock
- News Chemomab Therapeutics Ltd.
- Oppenheimer Adjusts Chemomab Therapeutics' Price Target to $20 From $30, Maintains Outperform Rating